Genomic data is being produced in ever greater quantities, whether within our health services, in academic research projects, or by the commercial sector. It has been estimated that 60 million people will have had their genome sequenced in healthcare contexts alone, by 2025. But to maximise the value and understanding that we can gain from … Continue reading →